Go to content
Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 04 mei 2016 - 08:10
Statutaire naam Vivoryon Therapeutics N.V.
Titel Probiodrug AG to Publish its First Quarter 2016 Business Update on May 12, 2016
Bericht Probiodrug AG to Publish its First Quarter 2016 Business Update on May 12, 2016 HALLE/SAALE, Germany, 4 May 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), will publish its first quarter business update for the period ended 31 March 2016 on Thursday, May 12, 2016, in the form of an interim management report.